SABBIONI, Silvia
 Distribuzione geografica
Continente #
NA - Nord America 5.786
EU - Europa 1.439
AS - Asia 815
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 8.046
Nazione #
US - Stati Uniti d'America 5.783
CN - Cina 579
UA - Ucraina 342
IT - Italia 319
TR - Turchia 192
DE - Germania 183
GB - Regno Unito 179
PL - Polonia 153
SE - Svezia 106
FI - Finlandia 78
RO - Romania 23
FR - Francia 19
BE - Belgio 13
IN - India 11
VN - Vietnam 9
KR - Corea 8
AT - Austria 5
HK - Hong Kong 4
IR - Iran 4
NL - Olanda 4
RU - Federazione Russa 4
BR - Brasile 3
CA - Canada 3
GR - Grecia 3
CZ - Repubblica Ceca 2
HU - Ungheria 2
SG - Singapore 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BG - Bulgaria 1
CH - Svizzera 1
EU - Europa 1
IE - Irlanda 1
JP - Giappone 1
KZ - Kazakistan 1
MK - Macedonia 1
MY - Malesia 1
NP - Nepal 1
PH - Filippine 1
UZ - Uzbekistan 1
Totale 8.046
Città #
Fairfield 815
Woodbridge 725
Ashburn 456
Houston 438
Chandler 416
Jacksonville 383
Ann Arbor 364
Seattle 323
Wilmington 300
Cambridge 270
Warsaw 152
Beijing 135
Izmir 134
Nanjing 125
New York 110
Ferrara 104
Princeton 93
San Diego 74
Milan 66
Boardman 63
Dearborn 58
Shanghai 58
Nanchang 45
Shenyang 29
Washington 25
Jinan 23
Los Angeles 22
Tianjin 22
Falls Church 21
San Mateo 20
Addison 18
Bremen 18
Changsha 18
Hebei 18
Mountain View 18
Timisoara 17
Norwalk 16
Bologna 15
Jiaxing 15
London 15
Guangzhou 14
Auburn Hills 13
Ningbo 13
Kunming 12
Augusta 11
Brussels 11
Redwood City 11
Zhengzhou 11
Dong Ket 9
Philadelphia 9
Verona 9
Hangzhou 7
Leawood 7
Orange 7
San Giorgio Di Piano 7
Tappahannock 7
Ferrara di Monte Baldo 6
Rome 6
Des Moines 5
Helsinki 5
Monmouth Junction 5
Prescot 5
Taizhou 5
Vienna 5
Chicago 4
Hefei 4
Hong Kong 4
Indiana 4
Kilburn 4
Pune 4
Redmond 4
Berkeley 3
Castelmassa 3
Changchun 3
Haikou 3
Lanzhou 3
Leeds 3
Mumbai 3
Acton 2
Altamura 2
Ardabil 2
Bolzano 2
Celldömölk 2
Chiswick 2
Fiesole 2
Florence 2
Focsani 2
Hounslow 2
Maserà di Padova 2
Modena 2
Monte San Pietro 2
Montichiari 2
Palermo 2
Pasadena 2
Pearland 2
San Jose 2
Tallahassee 2
Thessaloníki 2
Toronto 2
Trieste 2
Totale 6.330
Nome #
MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches 285
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model 166
Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR 159
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 150
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer 142
Anti-Tumor Activity of a miR-199-dependent Oncolytic Adenovirus 141
miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model 140
p53/MDM2 Feed-back Loop Sustains miR-221 Expression and Dictates the Response to Anticancer Treatments in Hepatocellular Carcinoma 138
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 136
Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin's lymphoma: Correlation with clinicobiologic features 128
Refined subchromosomal location of 21 expressed sequence tags from unknown genes at region 11p15 128
Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma 128
Multiple loci on human chromosome 11 control tumorigenicity of BK virus transformed cells 127
MicroRNA expression changes during human leukemic HL-60 cell differentiation induced by 4-hydroxynonenal, a product of lipid peroxidation 126
MicroRNA involvement in hepatocellular carcinoma 124
Transcriptional map of 170-kb region at chromosome 11p15.5: Identification and mutational analysis of the BWR1A gene reveals the presence of mutations in tumor samples 123
A novel t(9;11)(p22;q23) with ALL-1 gene rearrangement associated with progression of a myeloproliferative disorder to acute myeloid leukemia 122
In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2 117
Anticancer activity of an adenoviral vector expressing short hairpin RNA against BK virus T-ag 115
microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters 113
MicroRNA response to environmental mutagens in liver 110
Whole metagenomic shotgun sequencing of the subgingival microbiome of diabetics and non-diabetics with different periodontal conditions 108
null 107
A BK virus episomal vector for constitutive high expression of exogenous cDNAs in human cells 106
Simian virus 40 infection in humans and association with human diseases: results and hypotheses 104
Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients 104
Animal Models of Hepatocellular Carcinoma Prevention 104
Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival 103
null 103
t(4;11)(q21;p15) translocation involving NUP98 and RAP1GDS1 genes: characterization of a new subset of T acute lymphoblastic leukaemia 102
microRNA involvement in hepatocellular carcinoma 101
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality 101
Open letter to Senator Rita Levi-Montalcini. 99
Prevalence of liver tumours in HIV-1 tat-transgenic mice treated with urethane 99
Circulating microRNA quantification using DNA-binding dye chemistry and droplet digital PCR 99
MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells 99
BK virus, JC virus and simian virus 40 infection in humans, and association with human tumors 97
Subchromosomal assignment of the TSSC1 gene to human chromosome band 11p15.5 near the HBB gene cluster 96
Metformin prevents liver tumourigenesis by attenuating fibrosis in a transgenic mouse model of hepatocellular carcinoma 95
null 94
null 94
null 93
Investigations on microRNAs in human chronic lymphocytic leukemia and control of cancer-associated molecular pathways 92
Non-coding RNAs in the reprogramming of glucose metabolism in cancer 91
Nidogen 1 and 2 gene promoters are aberrantly methylated in human gastrointestinal cancer 90
null 89
High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B 88
Exon structure and promoter identification of STIM1 (alias GOK), a human gene causing growth arrest of the human tumor cell lines G401 and RD 85
Espressione dei MicroRNA nei carcinomi mammari 85
BK virus, JC virus and Simian Virus 40 infection in humans, and association with human tumors. In: POLYOMAVIRUSES AND HUMAN DISEASES 84
Sensitive and specific detection of lung cancer DNA in bronchial washing by a novel methylation-specific droplet digital PCR 84
Tumorigenicity and anchorage-independent growth suppression of BK virus transformed mouse cells by human chromosome 11 81
Circulating tumor DNAs and non-coding RNAs as potential biomarkers for hepatocellular carcinoma diagnosis, prognosis and response to therapy 81
null 80
Frequent aberrant methylation of the CDH4 gene-promoter in human colorectal and gastric cancer 78
Characterization of BKV variants rescued from human tumors and tumor cell lines 77
Prevalence of the archetypal regulatory region and sequence polymorphisms in non passaged BK virus variants 75
EPIGENETIC CHANGES AT CHROMOSOME REGION 11p15.5 IN HUMAN CANCER 75
Multigene methylation analysis of gastrointestinal tumors: TPEF emerges as a frequent tumor-specific aberrantly methylated marker that can be detected in peripheral blood 73
null 72
Emerging role of microRNAs in the treatment of hepatocellular carcinoma 72
MGMT expression in colorectal cancer: relation to clinicopathologic and molecular features 71
miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model 71
An in vitro method for the diagnosis of neoplastic diseases by methylation analysis of the CDH4 gene, oligonucleotides and kits useful in such method 70
Uso di modelli di trasformazione virale nello studio dei geni oncosoppressori tramite trasferimento monocromosomico. 69
t(4;11)(q21;p15) translocation involving NUP98 and RAP1GDS1 genes. Characterization of a new subset of T-ALL 68
Espressione del gene MGMT nel carcinoma colo-rettale: correlazioni cliniche, patologiche e biomolecolari 68
CHARACTERIZATION OF CHROMOSOMAL REGION 11p15 FOR THE IDENTIFICATION OF GENES INVOLVED IN BECKWITH-WIEDEMANN SYNDROME 65
CHARACTERIZATION OF CHROMOSOMAL REGION 11p15 FOR THE IDENTIFICATION OF GENES INVOLVED IN BECKWITH-WIEDEMANN SYNDROME 63
null 63
Simian virus 40 in humans. 60
Seven Mb YAC contig at region 11p15.5: identification of a YAC spanning the breakpoint of a chromosomal translocation found in a case of Beckwith-Wiedemann syndrome 58
CLONING AND CHARACTERIZATION OF A CLUSTER OF IMPRINRTED GENES AT 11p15.5 AND THEIR INVOLVEMENT IN TUMORIGENESIS. 58
Tumor and growth suppression of breast cancer cells by chromosome 17-associated functions 56
Suppression of breast cancer cells tumorigenicity by microcell mediated chromosome transfer: studies on chromosomes 6 and 11 51
CHARACTERIZATION OF CHROMOSOMAL REGION 11p15 FOR THE IDENTIFICATION GENES INVOLVED IN BECKWITH-WIEDEMANN SYNDROME. 50
GOK: a gene at 11p15 involved in rhabdomyosarcoma and rhabdoid tumor development 50
MINT31 methylation in gastric noninvasive neoplasia: potential role in the secondary prevention of gastric cancer 50
Down-regulation of bcl-2 by p53 in breast cancer cells 48
Micro SPECT-CT Preliminary Imaging Evaluation in an Experimental Animal Model for evaluation of oncogenic role of microRNAs in Hepatocellular Carcinoma 45
DEFINITION AND REFINEMENT OF CHROMOSOME-11 REGIONS OF LOSS OF HETEROZYGOSITY IN BREAST-CANCER - IDENTIFICATION OF A NEW REGION AT 11Q23.3 43
Suppression of tumorigenesis by the breast cancer cell line MCF-7 following transfer of a normal human chromosome 11 40
Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer 40
null 37
Inhibiting the oncogenic mir-221 by microRNA sponge: Toward microRNA-based therapeutics for hepatocellular carcinoma 26
Reconstruction of Acinetobacter johnsonii ICE_NC genome using hybrid de novo genome assemblies and identification of the 12α-hydroxysteroid dehydrogenase gene 25
A comprehensive approach for microbiota and health monitoring in mouse colonies using metagenomic shotgun sequencing 23
microRNAs and Inflammatory Immune Response in SARS-CoV-2 Infection: A Narrative Review 23
Novel Virus Identification through Metagenomics: A Systematic Review 21
Erratum: miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models 20
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma 20
The methylator phenotype in microsatellite stable colorectal cancers is characterized by a distinct gene expression profile 20
Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with "Oncogene-Addicted" Advanced Lung Adenocarcinoma: A Real-World Clinical Study 19
Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA 19
MicroRNA gene expression deregulation in human breast cancer 16
miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs 16
MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma 15
Role of microRNAs in hepatocellular carcinoma: a clinical perspective 12
MicroRNAs in human hepatocarcinoma and their potential use as therapeutic agents: an experimental animal model and preliminary imaging evaluation 12
miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models 12
Totale 8.171
Categoria #
all - tutte 30.420
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 870
Totale 31.290


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019394 0 0 0 0 0 0 0 0 0 0 0 394
2019/20201.984 275 58 58 305 133 243 202 202 168 203 74 63
2020/20211.412 103 139 163 133 58 117 49 132 35 230 168 85
2021/20221.018 27 83 104 45 46 53 62 51 44 69 96 338
2022/2023966 95 69 34 132 152 124 64 90 118 6 43 39
2023/2024593 45 71 39 20 65 207 33 62 16 13 11 11
Totale 8.195